[HTML][HTML] Neurogenic inflammation: The participant in migraine and recent advancements in translational research

E Spekker, M Tanaka, Á Szabó, L Vécsei - Biomedicines, 2021 - mdpi.com
Migraine is a primary headache disorder characterized by a unilateral, throbbing, pulsing
headache, which lasts for hours to days, and the pain can interfere with daily activities. It …

[HTML][HTML] Calcitonin gene-related peptide (CGRP)-targeted monoclonal antibodies and antagonists in migraine: current evidence and rationale

F Cohen, H Yuan, SD Silberstein - BioDrugs, 2022 - Springer
Calcitonin gene-related peptide (CGRP), a 37 amino-acid neuropeptide found mostly in
peptidergic sensory C-fibers, has been suggested to be implicated in the pathogenesis of …

[HTML][HTML] The kynurenine pathway as a potential target for neuropathic pain therapy design: from basic research to clinical perspectives

K Ciapała, J Mika, E Rojewska - International Journal of Molecular …, 2021 - mdpi.com
Accumulating evidence suggests the key role of the kynurenine pathway (KP) of the
tryptophan metabolism in the pathogenesis of several diseases. Despite extensive research …

[HTML][HTML] Co-players in chronic pain: neuroinflammation and the tryptophan-kynurenine metabolic pathway

M Tanaka, N Török, F Tóth, Á Szabó, L Vécsei - Biomedicines, 2021 - mdpi.com
Chronic pain is an unpleasant sensory and emotional experience that persists or recurs
more than three months and may extend beyond the expected time of healing. Recently …

[HTML][HTML] TRPA1-mediated Src family kinases activity facilitates cortical spreading depression susceptibility and trigeminovascular system sensitization

L Nie, L Jiang, JP Quinn, BD Grubb… - International Journal of …, 2021 - mdpi.com
Transient receptor potential ankyrin 1 (TRPA1) plays a role in migraine and is proposed as a
promising target for migraine therapy. However, TRPA1-induced signaling in migraine …

[HTML][HTML] Unmet needs for migraine

P Martelletti, M Curto - Current Medical Research and Opinion, 2021 - Taylor & Francis
Migraine is a neurological disease that affects approximately one billion of individuals
worldwide, and has been considered by the Global Burden of Diseases 2019 as the second …

The first report of the Italian Migraine Registry (I-GRAINE)

P Barbanti, G Egeo, C Aurilia, G Fiorentini… - Neurological …, 2022 - Springer
Abstract Italian Migraine Registry (I-GRAINE) is a multicenter (n= 38), prospective,
observational, non-interventional study aimed at providing big data on migraine to ensure …

Triptans and vascular comorbidity in persons over fifty: Findings from a nationwide insurance database–A cohort study

K Zebenholzer, W Gall, A Gleiss… - … : The Journal of …, 2022 - Wiley Online Library
Objective To gather information about prescription of triptans and to evaluate whether
vascular comorbidity differs in users and nonusers of triptans over the age of 50 years …

[HTML][HTML] Are indirect comparisons for treatments in migraine necessitas? Many inevitable challenges to overcome

C Deligianni, P Martelletti… - Journal of Comparative …, 2023 - becarispublishing.com
In recent years there has been a flurry of novel antimigraine treatments targeting specific
pathways that have been shown to be involved in its pathophysiology, like the calcitonin …

Novel pharmacological targets of migraine: An overview

E Rivera-Mancilla, A MaassenVanDenBrink - Novel Synthetic Drugs in …, 2022 - Springer
Despite all studies during the last decades, the exact pathophysiological mechanisms
underlying the onset of a migraine attack are not yet fully characterized. Notwithstanding, the …